BRIEF-Astrazeneca Says Enhertu Granted Priority Review For Her2m NSCLC

Reuters | Updated: 19-04-2022 11:58 IST | Created: 19-04-2022 11:50 IST

BRIEF-Astrazeneca Says Enhertu Granted Priority Review For Her2m NSCLC — Representative Image Image Credit: Twitter (@AstraZeneca)

AstraZeneca PLC:

* ASTRAZENECA PLC - ENHERTU GRANTED PRIORITY REVIEW FOR HER2M NSCLC Source text for Eikon: Further company coverage:

TRENDING

1

UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks in Court

UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks i...

Global

2

Hormuz Shock Forces a Rethink of How the World Secures Energy

Hormuz Shock Forces a Rethink of How the World Secures Energy

Global

3

EXCLUSIVE-Anthropic leaders to control AI lab via 'Founder LLC' to promote public good over market forces

EXCLUSIVE-Anthropic leaders to control AI lab via 'Founder LLC' to promote p...

Global

4

EXCLUSIVE-Anthropic's IPO prospectus shows sweeping AI vision, surging costs

EXCLUSIVE-Anthropic's IPO prospectus shows sweeping AI vision, surging costs

Global

PERSPECTIVES AND INSIGHTS

Beyond the AI Hype: Sierra Leone Bets on Data, Skills and Connectivity to Drive Real Development

Eurasia’s Middle Corridor Faces a $55 Billion Test to Turn Connectivity Into Economic Growth

The Double-Edged Network: How Global Trade Shares Risk and Spreads Contagion

AI, ESG and Trust Are Becoming Interdependent Pillars of Digital Finance

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter